SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Neurochem, Inc. Receives Approvable Letter for Eprodisate (KIACTA(TM)) for Treatment of AA Amyloidosis; FDA Asks for More Data